Therapeutic use of newer antiviral agents.
D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000956:Antigens, Viral / Q000276:immunology; D000998:Antiviral Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000187:drug effects / Q000472:pathogenicity; D004279:DNA, Viral / Q000378:metabolism; D015774:Ganciclovir; D006561:Herpes Simplex / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D006562:Herpes Zoster / Q000188:drug therapy / Q000503:physiopathology; D004854:Herpesvirus 4, Human / Q000472:pathogenicity; D006801:Humans; D018139:Simplexvirus / Q000472:pathogenicity / Q000648:ultrastructure
D000956:Antigens, Viral; D000998:Antiviral Agents; D004279:DNA, Viral; C020235:brivudine; D001973:Bromodeoxyuridine; D015774:Ganciclovir; D000212:Acyclovir